Gender differences in thrombogenicity among patients with angina and non-obstructive coronary artery disease.


Journal

Journal of thrombosis and thrombolysis
ISSN: 1573-742X
Titre abrégé: J Thromb Thrombolysis
Pays: Netherlands
ID NLM: 9502018

Informations de publication

Date de publication:
Oct 2019
Historique:
pubmed: 21 6 2019
medline: 20 2 2020
entrez: 21 6 2019
Statut: ppublish

Résumé

Women more often present with angina and non-obstructive coronary artery disease (ANOCA) and have poorer clinical outcomes than men. These findings may be related to sex associated differences in inflammation and thrombogenicity. Consecutive patients (n = 134) with ANOCA (luminal diameter stenosis < 50%) undergoing elective cardiac catheterization were included in post hoc analysis of Multi-Analyte, thrombogenic, and Genetic Markers of Atherosclerosis (MAGMA, NCT01276678) study. Patients with prior revascularization, coronary artery bypass grafting or myocardial infarction were excluded. Blood for thromboelastography, oxidized LDL β2-glycoprotein complex (AtherOx), oxidized-LDL, lipid profile, and urine for 11-dehydrothromboxane B

Identifiants

pubmed: 31218482
doi: 10.1007/s11239-019-01901-1
pii: 10.1007/s11239-019-01901-1
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

373-381

Références

Eur J Clin Invest. 2000 Aug;30(8):685-94
pubmed: 10964160
Circulation. 2004 Jun 22;109(24):2993-9
pubmed: 15197152
Coron Artery Dis. 2004 Aug;15(5):259-64
pubmed: 15238822
J Am Coll Cardiol. 2005 Nov 15;46(10):1820-6
pubmed: 16286165
J Am Coll Cardiol. 2006 Feb 7;47(3 Suppl):S21-9
pubmed: 16458167
Diabetologia. 2006 Jun;49(6):1380-6
pubmed: 16596357
Am Heart J. 2006 Oct;152(4):641-7
pubmed: 16996828
Diabetes Care. 2008 Apr;31(4):776-82
pubmed: 18184901
Eur Heart J. 2008 Jun;29(11):1359-69
pubmed: 18424787
Blood Coagul Fibrinolysis. 2008 Jun;19(4):268-75
pubmed: 18469547
Arch Intern Med. 2009 May 11;169(9):843-50
pubmed: 19433695
J Cardiol. 2009 Jun;53(3):317-33
pubmed: 19477372
JAMA. 2009 Aug 26;302(8):874-82
pubmed: 19706861
Am Heart J. 2009 Oct;158(4):688-94
pubmed: 19781432
J Am Coll Cardiol. 2010 Jun 22;55(25):2825-32
pubmed: 20579539
J Interv Cardiol. 2010 Dec;23(6):511-9
pubmed: 21029178
Clin Chem. 2011 Aug;57(8):1196-200
pubmed: 21697499
J Clin Invest. 2011 Jul;121(7):2693-708
pubmed: 21701070
Circulation. 2011 Sep 27;124(13):1414-25
pubmed: 21900087
Eur Heart J. 2012 Mar;33(6):734-44
pubmed: 21911339
Circulation. 2011 Sep 27;124(13):1477-80
pubmed: 21947935
Heart Fail Clin. 2012 Oct;8(4):589-607
pubmed: 22999242
Arteriosclerosis. 1990 Jul-Aug;10(4):520-30
pubmed: 2369363
Am Heart J. 2013 Jul;166(1):38-44
pubmed: 23816019
PLoS One. 2014 Jun 17;9(6):e99783
pubmed: 24937192
J Am Coll Cardiol. 2014 Jul 29;64(4):337-45
pubmed: 25060366
J Invasive Cardiol. 2014 Aug;26(8):389-93
pubmed: 25091099
J Am Heart Assoc. 2014 Oct 20;3(5):e001167
pubmed: 25332180
Eur Heart J Acute Cardiovasc Care. 2016 Feb;5(1):43-54
pubmed: 25681487
Circulation. 2015 Mar 24;131(12):1044-6
pubmed: 25712204
Circulation. 2015 Mar 24;131(12):1054-60
pubmed: 25712205
J Am Coll Cardiol. 2015 Oct 27;66(17):1918-33
pubmed: 26493665
J Interv Cardiol. 2016 Apr;29(2):168-78
pubmed: 26822493
J Diabetes Complications. 2016 Sep-Oct;30(7):1365-70
pubmed: 27237049
Am J Cardiol. 2016 Sep 1;118(5):673-8
pubmed: 27401271
Clin Physiol Funct Imaging. 2018 Mar;38(2):246-253
pubmed: 28168796
Int J Cardiol Heart Vasc. 2015 Jul 30;8:161-166
pubmed: 28785696
Eur Heart J Acute Cardiovasc Care. 2019 Feb;8(1):54-62
pubmed: 29952633
Circulation. 1997 Nov 18;96(10):3287-93
pubmed: 9396418

Auteurs

Rahul Chaudhary (R)

Sinai Hospital of Baltimore, Baltimore, MD, USA.
Division of Hospital Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Indiana University, Bloomington, IN, USA.

Ajaypaul Sukhi (A)

Sinai Hospital of Baltimore, Baltimore, MD, USA.

Rohit Chaudhary (R)

Peter Lee Associates, Sydney, Australia.

Manila Jindal (M)

Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Fairfax, VA, USA.

Ankit Vyas (A)

Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Fairfax, VA, USA.

Amit Rout (A)

Sinai Hospital of Baltimore, Baltimore, MD, USA.

Kevin Bliden (K)

Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, Fairfax, VA, USA.

Udaya Tantry (U)

Platelet and Thrombosis Research, Baltimore, MD, USA.

Paul Gurbel (P)

Interventional Cardiology and Cardiovascular Medicine Research, Inova Center for Thrombosis Research and Drug Development, Inova Heart and Vascular Institute, 3300 Gallows Road, Falls Church, VA, 22042, USA. Paul.Gurbel@inova.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH